EM18: Research, Development, and Innovation in Maternal-Fetal Medicine and Gynecologic Oncology

The EM18 group is dedicated to research, development, and innovation in maternal-fetal medicine and gynecologic oncology. Its work focuses on improving women's health through applied research and collaboration with healthcare centers and universities.

Responsible researcher

Juan Jesús Fernández Alba:
- E-mail: jjesus.fernandez@uca.es
- ORCID: 0000-0002-7297-6876

Lines of research

Line 1: Diagnosis and management of fetal growth disorders.
Line 2: Quality of life in patients with breast cancer.
Line 3: General. Epidemiology, evidence-based healthcare interventions, and analysis of outcomes in Maternal-Fetal Medicine and Gynecologic Oncology at the Department of Obstetrics and Gynecology at the University Hospital of Puerto Real.

Keywords

# Maternal-Fetal Diseases
# Breast Cancer
# Maternal-Fetal Medicine

EM18: Research, Development, and Innovation in Maternal-Fetal Medicine and Gynecologic Oncology

Responsible researcher

Juan Jesús Fernández Alba:

Puerto Real University Hospital: Chief of the Obstetrics and Gynecology Department || University of Cádiz: Associate Professor of Health Sciences, affiliated with the Department of Maternal and Child Health and Radiology.

E-mail: jjesus.fernandez@uca.es
ORCID: 0000-0002-7297-6876

Members of the Team

Principal Investigators:
- Juan Jesús Fernández Alba (PI).
Researchers:
- Ángel Vilar Sánchez.
- Carmen González Macías.
- Estefanía Serrano Negro.
- Estefanía Soto Pazos.
- María Castillo Lara.
- Rocío Quintero Prado.
- Rocío Moreno Cortés.

EM18: Research, Development, and Innovation in Maternal-Fetal Medicine and Gynecologic Oncology

Production

Find all of the group's publications ( Projects, Patents , and Publications) on the I+Salud Portal of the Andalusian Public Health System: